HealthcareServices

Genomic Selection Platform Market Trends and Insights: Global Forecast to 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genomic selection platform market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Genomic Selection Platform Market covering 2026–2035?

The genomic selection platform market has shown rapid expansion in recent years. It is anticipated to increase from $2.27 billion in 2025 to $2.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.1%. The historical growth was primarily driven by the expansion of molecular breeding programs, the increasing availability of genotyping technologies, the adoption of statistical genomics models, a rising demand for faster breeding cycles, and growing research investments in genetics.

The genomic selection platform market is projected for substantial expansion in the coming years, with its valuation forecast to reach $4.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.8%. This anticipated growth throughout the forecast period stems from factors such as the increasing uptake of genomic selection within agriculture, the growing application of predictive analytics in breeding initiatives, the broadening of sustainable crop and livestock development efforts, the rising integration of genomics with precision agriculture, and the continuous advancement of cloud-native genomic platforms. Key trends anticipated during this period encompass the increasing adoption of AI-driven genomic prediction models, the rising utilization of high-throughput genotyping platforms, the growing integration of cloud-based breeding analytics, the expansion of predictive breeding decision support systems, and a heightened emphasis on trait-based selection accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Genomic Selection Platform Market?

The growing acceptance of personalized medicine is anticipated to fuel the expansion of the Genomic Selection Platform Market moving forward. Personalized medicine involves a medical strategy that customizes treatment and prevention plans based on an individual’s distinct genetic profile, lifestyle, and surroundings. This rise in personalized medicine adoption is largely attributed to developments in genomics, which allow for the accurate detection of genetic variations and the creation of customized treatments. Genomic selection platforms bolster personalized medicine by offering precise genomic data, making them highly suitable for customizing patient treatments. They minimize experimental therapy choices by forecasting intervention responses, thus enhancing treatment efficacy and patient outcomes. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022. Consequently, the increasing adoption of personalized medicine is a key driver for the Genomic Selection Platform Market’s growth.

What Segments Are Identified Within The Structure Of The Genomic Selection Platform Market?

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

What Trends Are Expected To Impact The Competitive Landscape Of The Genomic Selection Platform Market?

Leading companies in the genomic selection platform market are concentrating on creating advanced solutions, including targeted sequencing platforms, with the aim of enhancing trait prediction and expediting breeding initiatives. These platforms represent genomic technologies and systems specifically engineered to sequence particular parts of the genome instead of its entirety. A notable example is Element Biosciences Inc., a US-based life sciences technology firm, which introduced Trinity in October 2024. This groundbreaking targeted sequencing platform simplifies exome capture by incorporating traditionally intricate procedures directly into its AVITI System. This platform obviates the necessity for specialized machinery, cuts down manual labor by up to five hours, and provides a one-hour hybridization alternative for results within the same day, proving highly suitable for studies with tight deadlines. Trinity’s capabilities extend to supporting personalized panels for various applications, including oncology, respiratory diseases, and minimal residual disease (MRD). It facilitates more rapid, economical, and readily available sequencing, signifying the foremost significant progress in exome capture.

Which Major Firms Are Strengthening Their Position In The Genomic Selection Platform Market?

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Genomic Selection Platform Market?

North America was the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genomic Selection Platform Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28237&type=smp

Browse Through More Reports Similar to the Global Genomic Selection Platform Market 2026, By The Business Research Company

Bioinformatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795